Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.280
+0.130 (11.30%)
At close: Apr 13, 2026, 4:00 PM EDT
1.260
-0.020 (-1.55%)
After-hours: Apr 13, 2026, 6:02 PM EDT
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $218.06 million as of April 13, 2026. Its market cap has increased by 61.98% in one year.
Market Cap
218.06M
Enterprise Value
208.19M
1-Year Change
61.98%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $218.06M, a decrease of -57.59%. That is a compound annual growth rate of -17.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 195.92M | 37.10% |
| Dec 31, 2025 | 142.90M | 214.80% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
| Oct 14, 2021 | 514.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Profound Medical | 215.50M |
| Electromed | 199.60M |
| InfuSystem Holdings | 189.62M |
| CVRx, Inc. | 188.26M |
| Sight Sciences | 186.32M |
| Inogen | 172.38M |
| Apyx Medical | 165.64M |
| Quantum-Si incorporated | 160.22M |